Evidence-based protocols. Honest safety data. No supplements sold.
A reference for health-focused adults and practitioners researching peptide protocols. Evidence-based, condition-specific, and entirely free of commercial interest.
Tissue repair, wound healing, and injury recovery — what the evidence shows for BPC-157, TB-500, and related peptides.
Browse protocols →Peptide applications for metabolic conditions — insulin sensitivity, body composition, and related research.
Browse protocols →Growth hormone secretagogues, sex hormone axis peptides, and thyroid-interacting compounds.
Browse protocols →GI healing, mucosal repair, and anti-inflammatory peptide research with documented safety profiles.
Browse protocols →Before starting TB-500, the three things that matter most are: confirming the injury type is one with supporting preclinical data, using a conservative loading dose rather than starting at maintenance, and understanding that human trial evidence for musculoskeletal applications does not yet exist — outcomes are extrapolated from animal research.
Semax used for cognitive support is most effective at 300–600mcg intranasally, used on working days rather than daily. Overstimulation — reported as restlessness, disrupted sleep, or heightened anxiety — is almost always a dose or frequency issue, not an inherent property of the compound at therapeutic ranges.
The safest starting protocol for BPC-157 in 2026 is 250mcg subcutaneously once daily for 4 weeks, injected near the site of injury or discomfort. Starting low allows you to assess individual response before escalating. Most reported adverse effects occur at higher doses or with rapid escalation.
Every protocol article on Peptides Plus includes a structured safety section covering known adverse effects, contraindications, and evidence gaps. We treat incomplete evidence as information, not an excuse to omit warnings.
Where no controlled human safety data exists, that is stated explicitly. Where contraindications are documented, they are presented before dosing information, not after it. The deliberate, consistent placement of safety information is part of what makes this site useful — and what makes it responsibly citable.
Peptides Plus publishes evidence-based protocol summaries for health-focused adults and practitioners. No supplements are sold here. No content is sponsored. The editorial commitment is to accurate characterisation of evidence — including where it is preliminary, absent, or conflicted.